Categories Articles ‘Insufficient drug exposure’ may be to blame for Paxlovid ‘COVID rebound’ Post author By crystalg Post date July 21, 2022 Study Finds Tags blame, COVID, drug, exposure, insufficient, Paxlovid, Rebound ← Robinhood’s fractional trading drove a phantom surge in volume of Berkshire Hathaway’s hugely expensive Class A stock, according to study → Russia Pounds Major Ukrainian City After Expanding War Aims